![PDF) Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy PDF) Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy](https://i1.rgstatic.net/publication/6054236_Measurement_of_Residual_Breast_Cancer_Burden_to_Predict_Survival_After_Neoadjuvant_Chemotherapy/links/0046353c1ad0bc6182000000/largepreview.png)
PDF) Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
![Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41416-020-01251-3/MediaObjects/41416_2020_1251_Fig1_HTML.png)
Determination of breast cancer prognosis after neoadjuvant chemotherapy: comparison of Residual Cancer Burden (RCB) and Neo-Bioscore | British Journal of Cancer
![Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images](https://pub.mdpi-res.com/cancers/cancers-13-00011/article_deploy/html/images/cancers-13-00011-g001.png?1609221778)
Cancers | Free Full-Text | piNET–An Automated Proliferation Index Calculator Framework for Ki67 Breast Cancer Images
Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy | PLOS ONE
![Frontiers | A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer Frontiers | A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer](https://www.frontiersin.org/files/Articles/1119105/fendo-14-1119105-HTML-r1/image_m/fendo-14-1119105-g001.jpg)
Frontiers | A novel conditional survival nomogram for monitoring real-time prognosis of non-metastatic triple-negative breast cancer
![Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology](https://www.thelancet.com/cms/attachment/aebe7284-f489-4fa5-a13d-db5ed5bcba73/gr2_lrg.jpg)
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients - The Lancet Oncology
![A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect A scoping review of interactive and personalized web-based clinical tools to support treatment decision making in breast cancer - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S096097762101002X-gr1.jpg)